Testing the Addition of the Anti-cancer Viral Therapy Telomelysinâ„¢ to Chemoradiation for Patients With Advanced Esophageal Cancer and Are Not Candidates for Surgery
NRG Oncology
NRG Oncology
H. Lee Moffitt Cancer Center and Research Institute
Providence Health & Services
Carisma Therapeutics Inc
University College, London